3 September 2024
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Trading update for the six months ended 31 July 2024
Notice of interim results
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering specialist neonatal intensive care medical devices, is pleased to provide a trading update for the six months ended 31 July 2024.
Revenues for the period were
Revenues for the Infusion Therapies products grew by 16% to
Gross margin is expected to reduce to approximately 44.5% in the period as a result of the sales mix with increased sales of lower margin products.
At 31 July 2024, the Group's net debt (excluding IFRS16 lease liabilities) was
Commenting, Roy Davis, Executive Chair and Interim CEO of Inspiration Healthcare said: "Despite the challenges faced we have made progress during the period, securing our largest single order for our SLE6000 ventilators and completing a
Notice of interim results
The Group will be announcing interim results for the six months ended 31 July 2024 on Wednesday 2 October 2024.
The Company will provide a live presentation to investors via the Investor Meet Company platform on Monday, 7 October 2024 at 11am BST. The presentation will give an update on the Company and an overview of the Group's interim results for the six months ended 31 July 2024.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.
To register for the presentation, please use this link.
Investors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.
For further information, please contact:
Inspiration Healthcare Group plc |
Tel: +44 (0)330 175 0000 |
||
Roy Davis, Executive Chair and Interim Chief Executive Officer Alan Olby, Chief Financial Officer |
|
||
|
|
||
Panmure Liberum Limited (Nominated Adviser & Broker) |
Tel: +44 (0)20 3100 2000 |
||
Richard Lindley Will King Joshua Borlant |
|
||
|
|
||
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
||
Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
||
Stephanie Cuthbert |
Mob: +44 (0) 7796 794 663 |
||
Louis Ashe-Jepson |
Mob: +44 (0) 7747 515 393 |
||
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the
The Company operates in the
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.